NUI Galway's Neurent Medical has been backed by government investors WDC and Enterprise Ireland as it continues development on its rhinitis treatment device.
Neurent Medical, an Ireland-based rhinitis treatment spinout from NUI Galway, has received €9.3m ($10.9m) in a series A round led by life science-focused venture fund Fountain Healthcare Partners.
The round featured regional development agency Western Development Commission, Irish enterprise support agency Enterprise Ireland, growth equity fund Atlantic Bridge Capital and a range of unnamed angel investors.
Neurent Medical is developing a single-use medical device for treating rhinitis, a nasal inflammatory condition caused by allergens such as pollen or else by…